Hip prosthesis, pulmonary fibrosis, respiratory viruses, and GLP-1s

TT HealthWatch - July 10, 2026
Elizabeth Tracey and Dr. Richard Lange

This week's topics include a dual-action prosthesis for hip replacement, a new inhaled agent for idiopathic pulmonary fibrosis, testing nursing home residents for respiratory viruses, and online GLP-1 prescribing.

Program notes:

0:40 Online prescribing of GLP1s

1:44 Physician asks a number of questions

2:44 Interaction to approval about five minutes

3:30 Respiratory outbreak mitigation in nursing homes

4:30 Using PCR-based test in the nursing home

5:30 No difference in outbreak number or size

6:35 Avoid 64,000 ED transfers in U.S.

7:32 Residents reap many benefits

8:00 Inhalation treatment for pulmonary fibrosis

9:00 Clinical worsening in fewer patients

10:01 Dual-mobility total hip replacement

11:04 Substantially reduced risk of dislocation

12:05 Substantial number require revision previously

13:15 End

Next
Next

Technology to improve stroke outcomes, social media, and clinical management